Global Proteomics Market
Proteomics is the study of proteome which is a set of proteins present in the cell. Proteomes are different from one cell to another cell with requirements, stress, different time, and the organism.Proteomics help in the functioning and structure of the proteins used in the diagnosis, treatment, and drug discovery of various diseases. Moreover, proteomics also helps in the evaluation of protein production rate, the interaction between the proteins, protein modification, and involvement in the metabolic pathways. Proteomics needs various equipment, instruments, media, reagents, and, software for the identification, quantification, and interactions between the proteins.Increase in demand for personalized medicine, technological advancements for identification, increase in R&D activities by public and private sectors and rise in the prevalence of genetic disorders expected to boost the proteomics market over the forecast period.
Rise in the number of biopharmaceutical and pharmaceutical companies, growing healthcare expenditure, and increasing innovations in the genomics field expected to propel the proteomics market. However, stringent regulatory policies, lack of professionals for R&D activities, and a high cost of the devices and drugs might dampen the proteomics market revenue growth over the forecast period.
Proteomics market is segmented on the basis of product type, application, service type, and end user
Based on the product type, Global proteomics market is segmented into the following:
- Protein microarray
- X-ray Crystallography
- Protein fractionation system
Based on the service type, proteomics market is segmented into the following:
- Analytical laboratory services
- Protein sequencing
- Protein identification
- Protein separation
- Data analysis and maintenance
Based on the application, proteomics market is segmented into the following:
- Drug discovery
Based on the end user, proteomics market is segmented into the following:
- Biopharmaceutical and Pharmaceutical Companies
- Chemical industries
- Research institutes
Proteomics market is growing at a significant CAGR owing to increase in the demand for personalized medicine and rise R&D activities by Biopharmaceutical companies and research institutes. Government’s initiatives for prevention the genetic disorders are a key factor for fuel the proteomics market over the forecast period. Acquisitions & mergers, collaborations, and innovations are some key strategies followed by the companies for increasing their revenue in the Global proteomics market. For instance, in April 2014, Thermo Fisher Scientific has collaborated with Harward Medical School for the innovation of newer techniques for proteomics quantification. Similarly, in January 2012, Merck Millipore (Merck KGaA) has collaborated with Proteomics International for the evaluation of newly identified protein biomarkers under Merck’s multiplex immunoassays.
Geographically, Global proteomics market is segmented into North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa. The major factors anticipated to drive the North America proteomics market include the increase in funding from public and private sectors, developed healthcare infrastructure, increase in R&D activities, an increase in the demand for personalized medicine. Europe holds a key share in proteomics market, which is attributed to increasing the R&D activities for preventing the genetic disorders, technological advancements of instruments, and innovation of newer techniques are expected to propel the market in the region. Asia Pacific expected to exhibit lucrative growth over forecast timeframe owing to increase in the funding from public and private sectors, a rise in demand for quality healthcare and personalized medicine in the region.
Some of the players in Global proteomics market are Merck KGaA (Germany), Waters Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bruker Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), GE Healthcare (U.S.), Danaher Corporation (U.S.), and Luminex Corporation (U.S.) to name a few.
- In September 2016, Waters Corporation developed proteomics and lipidomics with Sonar (a novel mass spectrometry data acquisition) for the quantification and identification of proteins and lipids
- The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments, and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario